This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
3-5 November 2026
RAIAmsterdam, Netherlands

Shubhadra Pillay, PhD
Solutions Product Manager at Bruker BioSpin
Speaker

Profile

Shubhadra Pillay is a structural biologist and Solutions Product Manager at Bruker BioSpin, with expertise in NMR spectroscopy, molecular biophysics, and structure‑based drug design. Her current work focuses on advancing scalable, standardized NMR approaches for complex biomolecules, with particular emphasis on peptides and related therapeutic modalities. Her background includes fragment‑based lead optimization at Takeda Pharmaceuticals, postdoctoral research on ubiquitin dynamics using residual dipolar couplings at the Max Planck Institute, and PhD work on protein–nucleic acid interactions by NMR at Nanyang Technological University. Working at the interface of R&D, applications, and pharmaceutical development, she translates real discovery needs into robust, reproducible NMR methodologies that support drug discovery from early research through therapeutic development.

Agenda Sessions

  • Peptide Diversity and Therapeutics by NMR: Scalable Methods from Early Sequences to Drug Candidates

    11:50